1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine

C80H77BClN17O4 — CID 158637260

IUPAC1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine
SMILESCC1=NCc2ncc(-c3cncc(N4CCc5ccccc54)n3)cc21.COc1ccc(Cn2nc(C)c3cc(-c4cncc(N5CCc6ccccc65)n4)cnc32)cc1.COc1ccc(Cn2nc(C)c3cc(B4OC(C)(C)C(C)(C)O4)cnc32)cc1.Clc1cncc(N2CCc3ccccc32)n1
InChIInChI=1S/C27H24N6O.C21H26BN3O3.C20H17N5.C12H10ClN3/c1-18-23-13-21(14-29-27(23)33(31-18)17-19-7-9-22(34-2)10-8-19)24-15-28-16-26(30-24)32-12-11-20-5-3-4-6-25(20)32;1-14-18-11-16(22-27-20(2,3)21(4,5)28-22)12-23-19(18)25(24-14)13-15-7-9-17(26-6)10-8-15;1-13-16-8-15(9-23-18(16)11-22-13)17-10-21-12-20(24-17)25-7-6-14-4-2-3-5-19(14)25;13-11-7-14-8-12(15-11)16-6-5-9-3-1-2-4-10(9)16/h3-10,13-16H,11-12,17H2,1-2H3;7-12H,13H2,1-6H3;2-5,8-10,12H,6-7,11H2,1H3;1-4,7-8H,5-6H2
InChIKeyHZXSAANUPQZUOF-UHFFFAOYSA-N
MW1386.88 g/mol
LogP14.42
Rot. Bonds12

About 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine

1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine (PubChem CID 158637260) has the molecular formula C80H77BClN17O4 and a molecular weight of 1386.88 g/mol. Its IUPAC name is 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine.

Molecular Properties

Compound Name1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine
PubChem CID158637260
Molecular FormulaC80H77BClN17O4
Molecular Weight1386.88 g/mol
Exact Mass1385.61
IUPAC Name1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine
SMILESCC1=NCc2ncc(-c3cncc(N4CCc5ccccc54)n3)cc21.COc1ccc(Cn2nc(C)c3cc(-c4cncc(N5CCc6ccccc65)n4)cnc32)cc1.COc1ccc(Cn2nc(C)c3cc(B4OC(C)(C)C(C)(C)O4)cnc32)cc1.Clc1cncc(N2CCc3ccccc32)n1
InChIInChI=1S/C27H24N6O.C21H26BN3O3.C20H17N5.C12H10ClN3/c1-18-23-13-21(14-29-27(23)33(31-18)17-19-7-9-22(34-2)10-8-19)24-15-28-16-26(30-24)32-12-11-20-5-3-4-6-25(20)32;1-14-18-11-16(22-27-20(2,3)21(4,5)28-22)12-23-19(18)25(24-14)13-15-7-9-17(26-6)10-8-15;1-13-16-8-15(9-23-18(16)11-22-13)17-10-21-12-20(24-17)25-7-6-14-4-2-3-5-19(14)25;13-11-7-14-8-12(15-11)16-6-5-9-3-1-2-4-10(9)16/h3-10,13-16H,11-12,17H2,1-2H3;7-12H,13H2,1-6H3;2-5,8-10,12H,6-7,11H2,1H3;1-4,7-8H,5-6H2
InChIKeyHZXSAANUPQZUOF-UHFFFAOYSA-N
XLogP14.42
TPSA210.65 Ų
H-Bond Donors
H-Bond Acceptors21
Rotatable Bonds12
Heavy Atoms103
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001386.88
LogP ≤ 514.42
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(3,5-difluorophenyl)-8-(3-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;N-(3,5-difluorophenyl)-8-[3-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine;N-(3-fluorophenyl)-8-(3-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;8-(3-methoxyphenyl)-N-(2-methyl-4-pyridinyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine;8-(3-methoxyphenyl)-N-phenyl-[1,2,4]triazolo[1,5-a]pyridin-2-amine;8-(3-methoxyphenyl)-N-pyridin-4-yl-[1,2,4]triazolo[1,5-a]pyridin-2-amine
CID 157068880
6-[4-(1,1-Difluoroethoxy)phenyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine;6-[4-(1,1-difluoroethoxy)phenyl]-3-(trifluoromethyl)-[1,2,4]triazolo[3,4-f][1,2,4]triazine;3-(difluoromethyl)-6-(4-phenoxyphenyl)-[1,2,4]triazolo[4,3-a]pyrazine;6-(3,5-difluoro-4-phenoxyphenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine;6-(4-phenoxyphenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine;6-(4-phenoxyphenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine
CID 157166926
3-(1,1-Difluoroethyl)-6-[2-methyl-5-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine;3-(1,1-difluoroethyl)-6-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[4,3-a]pyrimidine;3-(1-fluoroethyl)-6-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[4,3-a]pyrazine;methane;6-[4-(trifluoromethoxy)phenyl]imidazo[1,2-a]pyrimidine
CID 157524145
Bis(2-tert-butyl-7-[(4-chlorophenyl)methyl]pyrrolo[2,3-b]pyridine);2-tert-butyl-7-[(5-fluoro-3-pyridinyl)methyl]pyrrolo[2,3-b]pyridine;bis(2-tert-butyl-7-[(3-methoxyphenyl)methyl]pyrrolo[2,3-b]pyridine);2-tert-butyl-7-[(4-methoxyphenyl)methyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-7-[(1-methylpyrazol-4-yl)methyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-7-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-7-[[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]methyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-7-(pyridin-3-ylmethyl)pyrrolo[2,3-b]pyridine
CID 157681198
5-(1,1-Difluoroethyl)-3-[2-methyl-4-(trifluoromethoxy)phenyl]imidazo[1,5-b]pyridazine;1-(1,1-difluoroethyl)-7-[4-(trifluoromethoxy)phenyl]imidazo[1,5-a]pyridine;8-(1,1-difluoroethyl)-2-[4-(trifluoromethoxy)phenyl]imidazo[1,5-a]pyrimidine;1-(1,1-difluoroethyl)-7-[4-(trifluoromethoxy)phenyl]imidazo[1,5-c]pyrimidine;3-[2-methyl-4-(trifluoromethoxy)phenyl]pyrrolo[1,2-b]pyridazine;3-[2-methyl-4-(trifluoromethoxy)phenyl]pyrrolo[1,2-c]pyrimidine;7-[4-(trifluoromethoxy)phenyl]indolizine;2-[4-(trifluoromethoxy)phenyl]pyrrolo[1,2-a]pyrimidine;3-[4-(trifluoromethoxy)phenyl]pyrrolo[1,2-c]pyrimidine
CID 157854114
14-Chloro-10-[2-(4-methoxyphenyl)ethyl]-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene;14-chloro-10-[2-[4-(trifluoromethyl)phenyl]ethyl]-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene;10-[2-(4-fluorophenyl)ethyl]-14-methyl-6,10,12,15-tetrazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11,13,15-tetraene;14-methyl-10-(2-phenylethyl)-6,10,12,15-tetrazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11,13,15-tetraene
CID 157963397
6-[4-(1,1-Difluoroethoxy)phenyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine;3-(difluoromethyl)-6-(4-phenoxyphenyl)-[1,2,4]triazolo[4,3-a]pyrazine;6-(3,5-difluoro-4-phenoxyphenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine;6-(4-phenoxyphenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine;6-(4-phenoxyphenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine
CID 157977598
6-[4-(1,1-Difluoroethoxy)-3-fluorophenyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine;6-[4-(1,1-difluoroethoxy)-2-methylphenyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine;6-[4-(1,1-difluoroethoxy)phenyl]-3-(difluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine;3-(difluoromethyl)-6-(4-phenoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazine;6-[6-(2,2-difluoropropoxy)-3-pyridinyl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine;6-(4-phenoxyphenyl)-3-(2,2,2-trifluoroethyl)-[1,2,4]triazolo[4,3-b]pyridazine
CID 158362604
3-Methyl-5-phenylpyrazolo[1,5-a]pyridine;3-methyl-5-phenylpyrazolo[1,5-a]pyrimidine;5-phenylpyrazolo[1,5-a]pyridine;6-[4-(trifluoromethoxy)phenyl]imidazo[1,2-a]pyrimidine
CID 158614642
2-chloro-6-(3,3-difluoropyrrolidin-1-yl)pyrazine;2,6-dichloropyrazine;3,3-difluoropyrrolidine;5-[6-(3,3-difluoropyrrolidin-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(3,3-difluoropyrrolidin-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine
CID 159483819
1-benzyl-2-tert-butyl-4-methylpyrrolo[2,3-b]pyridine;1-benzyl-2-tert-butyl-6-methylpyrrolo[2,3-b]pyridine;1-benzyl-2-(2,2-dimethylpropyl)pyrrolo[2,3-b]pyridine;1-benzyl-2-(2-methylpropyl)pyrrolo[2,3-b]pyridine;2-tert-butyl-1-[(4-chlorophenyl)methyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-1-[(5-fluoro-3-pyridinyl)methyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-1-[(3-methoxyphenyl)methyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-1-[(4-methoxyphenyl)methyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-1-[[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]methyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-1-[(1S)-1-phenylethyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-1-[(1R)-1-phenylethyl]pyrrolo[2,3-b]pyridine;2-tert-butyl-1-(1-phenylethyl)pyrrolo[2,3-b]pyridine
CID 159601427
3-(1,1-Difluoroethyl)-6-[2-(methoxymethyl)-4-(trifluoromethoxy)phenyl]imidazo[1,2-a]pyrimidine;3-(1,1-difluoroethyl)-6-[2-methyl-4-(trifluoromethoxy)phenyl]imidazo[1,2-a]pyrimidine;3-(1,1-difluoroethyl)-6-[4-(trifluoromethoxy)phenyl]imidazo[1,2-a]pyridine;2-methyl-6-[4-(trifluoromethoxy)phenyl]imidazo[1,2-a]pyrimidine;2-methyl-6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)imidazo[1,2-a]pyrimidine;6-[4-(trifluoromethoxy)phenyl]imidazo[1,2-a]pyrazine;6-[4-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazine
CID 159786004

Frequently Asked Questions

What is the IUPAC name of 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine?
The IUPAC name of 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine (CID 158637260) is 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine.
What is the SMILES notation for 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine?
The canonical SMILES for 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine is CC1=NCc2ncc(-c3cncc(N4CCc5ccccc54)n3)cc21.COc1ccc(Cn2nc(C)c3cc(-c4cncc(N5CCc6ccccc65)n4)cnc32)cc1.COc1ccc(Cn2nc(C)c3cc(B4OC(C)(C)C(C)(C)O4)cnc32)cc1.Clc1cncc(N2CCc3ccccc32)n1.
What is the InChIKey of 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine?
The InChIKey is HZXSAANUPQZUOF-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H24N6O.C21H26BN3O3.C20H17N5.C12H10ClN3/c1-18-23-13-21(14-29-27(23)33(31-18)17-19-7-9-22(34-2)10-8-19)24-15-28-16-26(30-24)32-12-11-20-5-3-4-6-25(20)32;1-14-18-11-16(22-27-20(2,3)21(4,5)28-22)12-23-19(18)25(24-14)13-15-7-9-17(26-6)10-8-15;1-13-16-8-15(9-23-18(16)11-22-13)17-10-21-12-20(24-17)25-7-6-14-4-2-3-5-19(14)25;13-11-7-14-8-12(15-11)16-6-5-9-3-1-2-4-10(9)16/h3-10,13-16H,11-12,17H2,1-2H3;7-12H,13H2,1-6H3;2-5,8-10,12H,6-7,11H2,1H3;1-4,7-8H,5-6H2.
What are the key properties of 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine?
1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine has a molecular weight of 1386.88 g/mol, XLogP of 14.42, 12 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(6-chloropyrazin-2-yl)-2,3-dihydroindole;5-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-1-[(4-methoxyphenyl)methyl]-3-methylpyrazolo[5,4-b]pyridine;3-[6-(2,3-dihydroindol-1-yl)pyrazin-2-yl]-5-methyl-7H-pyrrolo[3,4-b]pyridine;1-[(4-methoxyphenyl)methyl]-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[5,4-b]pyridine is sourced from PubChem (CID 158637260), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).